In the rearview are days when Oklahoma City’s key sectors – academia, aerospace, bioscience, energy, healthcare, manufacturing and research – worked solely in silos, and on the road ahead lie opportunities for those industries to cross, merge and collaborate, giving the city a future at becoming a stable, international competitor in the ever-changing global economy.
Existing companies with new and innovative projects that lead to diversification, market expansion, or supply chain resiliency may apply for OIEP. The one-year program leverages payroll tax rebates with private sector investments that promote a diversified and growing economy.
The board of directors for the Alliance for Economic Development of Oklahoma City have selected Assistant City Manager Kenton Tsoodle to succeed Cathy O’Connor as president and CEO of the Alliance. Tsoodle started in his new role March 25.
Advanced Call Center Technologies (ACT), an international company with offices in Montego Bay, Jamaica; Guatemala City, Guatemala; Douglas, Arizona; Carmichael, California; Junction City, Kansas; Harlingen, Texas; Johnson City, Tennessee; and Logan, Utah; announced they will be bringing up to 770 new jobs to Norman.
The Oklahoma City Convention & Visitors Bureau (OKC CVB) is excited to unveil a newly redesigned VisitOKC.com, featuring enhanced destination content, trip planning resources and web accessibility. Along with VisitOKC.com, the full redesign includes sites for Meetings and Sports event planners.
After welcoming the Congress for New Urbanism, the Oklahoma Youth Expo, Heartland Payment Systems Diamond Conference, the Team National 2022 Annual Convention, high school hoopsters, wrestlers and more recently, Oklahoma City is preparing to say hello to runners, collegiate strength coaches, jewelers, barrel racers, hydrocarbon measurers, college softball's best and more from all over the country visiting us soon and contributing to the success of our economy. Help us welcome them to Oklahoma City!
The shuttering of a major manufacturing facility can send shockwaves through any size community. When GM made the decision to close their OKC operation, the community saw an opportunity.
The highest dose of the investigational drug iberdomide showed a reduction of lupus symptoms by the end of a 24-week, Phase 2 study. OMRF physician-scientist Joan Merrill, M.D., was the lead author of the paper.
